Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting
Condition(s):Hearth Failure With Reduced Ejection Fraction (HFrEF)Last Updated:June 7, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Hearth Failure With Reduced Ejection Fraction (HFrEF)Last Updated:June 7, 2019Completed
Condition(s):Atrial Fibrillation Recurrent; HypertensionLast Updated:February 16, 2023Recruiting
Condition(s):Hypertension; Left Ventricular HypertrophyLast Updated:August 30, 2011Completed
Condition(s):Heart FailureLast Updated:October 7, 2021Completed
Condition(s):Acute Myocardial InfarctionLast Updated:October 6, 2022Completed
Condition(s):First Time Dual Chamber Pacemaker ImplantationLast Updated:April 12, 2023Terminated
Condition(s):Salt-sensitive HypertensionLast Updated:November 10, 2015Completed
Condition(s):Heart FailureLast Updated:February 7, 2024Completed
Condition(s):HypertensionLast Updated:June 20, 2019Completed
Condition(s):Stage 2 HypertensionLast Updated:May 2, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.